SCHEMBL20045015

SCHEMBL20045015

c1ccc(-c2ccc(-c3cc(-c4ccccc4)cc(-c4ccc(-c5ccc(-c6ccc(-c7ccc8oc9ccccc9c8c7)cc6)cc5)cc4)c3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.57
PLA2G4A P47712 5/20 0.57
PLA2G10 O15496 1/20 0.54
MAPT P10636 4/20 0.53
HPGD P15428 3/20 0.53
NPC1 O15118 3/20 0.53
KDM4E B2RXH2 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 2/20 0.53
AHR P35869 2/20 0.48
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
CA12 O43570 1/20 0.44
TNKS O95271 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20821583 1.00 PLA2G2A (0.57) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL804531 1.00 PLA2G2A (0.57) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL26820316 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL18698077 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL17228732 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL15836073 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL17827355 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL15836061 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL26820438 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD
SCHEMBL15836104 0.96 PLA2G2A (0.58) PLA2G2APLA2G4APLA2G10MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180102485-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2018-04-12 US disclosed
US-20180102485-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180102485-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT RER1, L1CAM, ESR1 PLA2G2A 4464/4885PLA2G4A 4680/4885PLA2G10 4562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.